• ASX set to retreat, Wall Street loses steam after Trump’s threat to ‘take out’ Iran; Oil rises
  • Neurocrine to Acquire Soleno Therapeutics for $2.9 Billion in Cash
  • Neurocrine Biosciences to Acquire Soleno Therapeutics for $2.9B
Soleno Therapeutics - Latest News and Information
  • All Technology
  • AI
  • Autonomy
  • B2B Growth
  • Big Data
  • BioTech
  • ClimateTech
  • Consumer Tech
  • Cybersecurity
  • DevOps
  • Digital Marketing
  • Ecommerce
  • EdTech
  • Enterprise
  • FinTech
  • GovTech
  • Hardware
  • HealthTech
  • HRTech
  • LegalTech
  • Nanotech
  • PropTech
  • Quantum
  • Robotics
  • SaaS
  • SpaceTech
AllNewsDealsSocialBlogsVideosPodcastsDigests

Technology Pulse

EMAIL DIGESTS

Daily

Every morning

Weekly

Tuesday recap

Top Publishers

  • The Verge AI

    The Verge AI

    21 followers

  • TechCrunch AI

    TechCrunch AI

    19 followers

  • Crunchbase News AI

    Crunchbase News AI

    15 followers

  • TechRadar

    TechRadar

    15 followers

  • Hacker News

    Hacker News

    13 followers

See More →

Top Creators

  • Ryan Allis

    Ryan Allis

    209 followers

  • Elon Musk

    Elon Musk

    80 followers

  • Sam Altman

    Sam Altman

    68 followers

  • Mark Cuban

    Mark Cuban

    57 followers

  • Jack Dorsey

    Jack Dorsey

    40 followers

See More →

Top Companies

  • SaasRise

    SaasRise

    211 followers

  • Anthropic

    Anthropic

    40 followers

  • OpenAI

    OpenAI

    22 followers

  • Hugging Face

    Hugging Face

    15 followers

  • xAI

    xAI

    12 followers

See More →

Top Investors

  • Andreessen Horowitz

    Andreessen Horowitz

    16 followers

  • Y Combinator

    Y Combinator

    15 followers

  • Sequoia Capital

    Sequoia Capital

    12 followers

  • General Catalyst

    General Catalyst

    8 followers

  • A16Z Crypto

    A16Z Crypto

    5 followers

See More →
NewsDealsSocialBlogsVideosPodcasts
HomeSoleno Therapeutics
Soleno Therapeutics logo

Soleno Therapeutics

0 followers

SLNO

Performance

About Soleno Therapeutics

Soleno Therapeutics is a biopharmaceutical company focused on the development and commercialization of novel therapeutics for the treatment of rare diseases. Headquartered in Redwood City, California, the company aims to bring therapies for life-threatening genetic disorders to patients and families worldwide. Its efforts emphasize translating promising research into clinically meaningful treatments for underserved rare-disease populations.

Recent News

ASX Set to Retreat, Wall Street Loses Steam After Trump’s Threat to ‘Take Out’ Iran; Oil Rises

Neurocrine to Acquire Soleno Therapeutics for $2.9 Billion in Cash

Recent Deals

Neurocrine Biosciences to Acquire Soleno Therapeutics for $2.9B

April 6, 2026

Key Team Members

Anish Bhatnagar, MD

Chairman of the Board and Chief Executive Officer

Neil M. Cowen, PhD, MBA

Senior Vice President, New Product Planning

Lauren Budesheim

Senior Vice President, People

Dairine Dempsey, PhD

Senior Vice President, Europe

Patricia C. Hirano, MPH

Senior Vice President, Regulatory Affairs

Key Facts

HQ Location

Redwood City, United States

Founded

1999

Employees

51 - 200

Status

Public

Website

https://soleno.life